Why the study?
Do transvenous endocardial cardioverter defibrillator systems improve clinical outcomes compared to conventional epicardial implants in patients with malignant ventricular tachyarrhythmias?
Population
Patients with malignant ventricular tachyarrhythmias
Comparison
Transvenous endocardial cardioverter… vs Conventional epicardial implants
Design
Review
Authors
Loading...
Supports transvenous ICD preference in practice; leaves open randomized confirmation versus contemporary alternatives.
Do transvenous endocardial cardioverter defibrillator systems improve clinical outcomes compared to conventional epicardial implants in patients with malignant ventricular tachyarrhythmias?
Transvenous endocardial ICD systems provide a less invasive, safer, and more cost-effective alternative to epicardial implants for managing malignant ventricular tachyarrhythmias.
Antonis S. Manolis (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: